ALLO
Price
$1.42
Change
+$0.13 (+10.08%)
Updated
Jun 6 closing price
Capitalization
282.16M
60 days until earnings call
BEAM
Price
$18.57
Change
+$1.58 (+9.29%)
Updated
Jun 6 closing price
Capitalization
1.87B
66 days until earnings call
Interact to see
Advertisement

ALLO vs BEAM

Header iconALLO vs BEAM Comparison
Open Charts ALLO vs BEAMBanner chart's image
Allogene Therapeutics
Price$1.42
Change+$0.13 (+10.08%)
Volume$3.48M
Capitalization282.16M
Beam Therapeutics
Price$18.57
Change+$1.58 (+9.29%)
Volume$3.9M
Capitalization1.87B
ALLO vs BEAM Comparison Chart
Loading...
ALLO
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
BEAM
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
View a ticker or compare two or three
VS
ALLO vs. BEAM commentary
Jun 07, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is ALLO is a StrongBuy and BEAM is a StrongBuy.

Interact to see
Advertisement
COMPARISON
Comparison
Jun 07, 2025
Stock price -- (ALLO: $1.42 vs. BEAM: $18.58)
Brand notoriety: ALLO and BEAM are both not notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: ALLO: 105% vs. BEAM: 176%
Market capitalization -- ALLO: $282.16M vs. BEAM: $1.87B
ALLO [@Biotechnology] is valued at $282.16M. BEAM’s [@Biotechnology] market capitalization is $1.87B. The market cap for tickers in the [@Biotechnology] industry ranges from $324.3B to $0. The average market capitalization across the [@Biotechnology] industry is $2.35B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

ALLO’s FA Score shows that 0 FA rating(s) are green whileBEAM’s FA Score has 1 green FA rating(s).

  • ALLO’s FA Score: 0 green, 5 red.
  • BEAM’s FA Score: 1 green, 4 red.
According to our system of comparison, BEAM is a better buy in the long-term than ALLO.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

ALLO’s TA Score shows that 5 TA indicator(s) are bullish while BEAM’s TA Score has 4 bullish TA indicator(s).

  • ALLO’s TA Score: 5 bullish, 3 bearish.
  • BEAM’s TA Score: 4 bullish, 4 bearish.
According to our system of comparison, ALLO is a better buy in the short-term than BEAM.

Price Growth

ALLO (@Biotechnology) experienced а +21.37% price change this week, while BEAM (@Biotechnology) price change was +17.34% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was +9.04%. For the same industry, the average monthly price growth was +14.90%, and the average quarterly price growth was +1.90%.

Reported Earning Dates

ALLO is expected to report earnings on Aug 06, 2025.

BEAM is expected to report earnings on Aug 12, 2025.

Industries' Descriptions

@Biotechnology (+9.04% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
BEAM($1.87B) has a higher market cap than ALLO($282M). BEAM YTD gains are higher at: -25.101 vs. ALLO (-33.333). ALLO has higher annual earnings (EBITDA): -243.33M vs. BEAM (-399.03M). BEAM has more cash in the bank: 1.22B vs. ALLO (292M). ALLO has less debt than BEAM: ALLO (90.8M) vs BEAM (158M). BEAM has higher revenues than ALLO: BEAM (63.6M) vs ALLO (22K).
ALLOBEAMALLO / BEAM
Capitalization282M1.87B15%
EBITDA-243.33M-399.03M61%
Gain YTD-33.333-25.101133%
P/E RatioN/AN/A-
Revenue22K63.6M0%
Total Cash292M1.22B24%
Total Debt90.8M158M57%
FUNDAMENTALS RATINGS
ALLO: Fundamental Ratings
ALLO
OUTLOOK RATING
1..100
4
VALUATION
overvalued / fair valued / undervalued
1..100
97
Overvalued
PROFIT vs RISK RATING
1..100
100
SMR RATING
1..100
94
PRICE GROWTH RATING
1..100
65
P/E GROWTH RATING
1..100
100
SEASONALITY SCORE
1..100
85

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

TECHNICAL ANALYSIS
Technical Analysis
ALLOBEAM
RSI
ODDS (%)
Bullish Trend 1 day ago
80%
N/A
Stochastic
ODDS (%)
Bearish Trend 1 day ago
90%
Bearish Trend 1 day ago
88%
Momentum
ODDS (%)
Bullish Trend 1 day ago
77%
Bullish Trend 1 day ago
82%
MACD
ODDS (%)
Bullish Trend 1 day ago
70%
Bullish Trend 1 day ago
89%
TrendWeek
ODDS (%)
Bullish Trend 1 day ago
76%
Bullish Trend 1 day ago
81%
TrendMonth
ODDS (%)
Bullish Trend 1 day ago
72%
Bullish Trend 1 day ago
80%
Advances
ODDS (%)
Bullish Trend 5 days ago
80%
Bullish Trend 4 days ago
78%
Declines
ODDS (%)
Bearish Trend 17 days ago
89%
Bearish Trend 9 days ago
85%
BollingerBands
ODDS (%)
Bearish Trend 1 day ago
90%
Bearish Trend 1 day ago
90%
Aroon
ODDS (%)
N/A
Bearish Trend 1 day ago
85%
View a ticker or compare two or three
Interact to see
Advertisement
ALLO
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
BEAM
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
MFs / NAMEPrice $Chg $Chg %
OMSNX26.09N/A
N/A
Invesco Main Street All Cap R
HAGCX51.83N/A
N/A
Carillon Eagle Mid Cap Growth C
BASVX13.18N/A
N/A
Brown Advisory Sustainable Val Inst
DGIFX23.82N/A
N/A
Disciplined Growth Investors
SGHIX11.21N/A
N/A
Saturna Global High Income

BEAM and

Correlation & Price change

A.I.dvisor indicates that over the last year, BEAM has been closely correlated with CRSP. These tickers have moved in lockstep 72% of the time. This A.I.-generated data suggests there is a high statistical probability that if BEAM jumps, then CRSP could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To BEAM
1D Price
Change %
BEAM100%
+9.26%
CRSP - BEAM
72%
Closely correlated
+8.53%
NTLA - BEAM
64%
Loosely correlated
+6.73%
RXRX - BEAM
63%
Loosely correlated
+20.13%
ABCL - BEAM
58%
Loosely correlated
+2.95%
VERV - BEAM
58%
Loosely correlated
+8.12%
More